View more arrow

View more CRI Funded Scientists

Paul Beavis, PhD

CRI Lloyd J. Old STAR

Dr. Paul Beavis is pioneering strategies to enhance CAR T cell therapy for solid cancers. His research focuses on overcoming immunosuppressive tumor environments, activating anti-tumor immunity, and improving CAR T cell persistence and penetration. With over 10,000 citations and significant publications in top-tier journals, Dr. Beavis is a renowned leader in the field. His innovative CAR T technology will enter a phase I clinical trial in 2025 at the Peter MacCallum Cancer Centre.

Projects and Grants

Enhancing the Efficacy of Adoptive Cellular Therapy through Advanced Genome Engineering

The University of Melbourne | All Cancers | 2024

Dot decoration
The University of Melbourne (Australia)
CRI Lloyd J. Old STAR
I would like to thank CRI for their vision in supporting high risk, high reward science. This award will improve my ability to access collaborative networks that will increase the significance and impact of my work.

You Can Help

You can help us make immunotherapy a cancer treatment option for more patients. Together, we can shift the focus from fighting cancer to overcoming cancer.

Donate

Explore More CRI Funded Scientists